FDA Inspection 802459 — Braden Partners LP D.B.A. Pacific Pulmonary Services

Braden Partners LP D.B.A. Pacific Pulmonary Services — FEI 3006222875

The FDA completed an inspection of Braden Partners LP D.B.A. Pacific Pulmonary Services on Oct 2, 2012 in Rockford, IL. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Oct 2, 2012
Fiscal Year
2013
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Rockford, IL (United States)